Studies show that GSK-3β inhibitors reduce the apoptosis induced by ERS, and valproate (2-propylpentanoic acid), via inhibiting the activity of GSK-3β, inhibits ERS-induced apoptosis [27]. The gene discussed is GSK3B; the disease is amelogenesis imperfecta type 1G.